Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,109Revenue (TTM) $M1,432Net Margin (%)24.8Altman Z-Score2.4
Enterprise Value $M10,022EPS (TTM) $5.7Operating Margin %37.2Piotroski F-Score7
P/E(ttm)23.6Beneish M-Score-2.3Pre-tax Margin (%)33.4Higher ROA y-yY
Price/Book4.810-y EBITDA Growth Rate %--Quick Ratio3.1Cash flow > EarningsY
Price/Sales5.95-y EBITDA Growth Rate %36.9Current Ratio3.2Lower Leverage y-yN
Price/Free Cash Flow24.4y-y EBITDA Growth Rate %0.6ROA % (ttm)9.5Higher Current Ratio y-yN
Dividend Yield %--PEG0.7ROE % (ttm)21.7Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M59.9ROIC % (ttm)17.9Gross Margin Increase y-yY

Gurus Latest Trades with JAZZ

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

JAZZ is held by these investors:



JAZZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MILLER MICHAEL PATRICKSVP, US Commercial 2017-02-15Sell200$134.550.3view
Cox Russell J.EVP & COO 2017-01-18Sell4,000$128.754.82view
MILLER MICHAEL PATRICKSVP, US Commercial 2017-01-17Sell200$115.9316.41view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-12-15Sell200$103.0930.91view
ENRIGHT PATRICK GDirector 2016-12-02Sell677$101.832.56view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-11-15Sell200$112.1920.29view
O'Keefe Kenneth WDirector 2016-11-14Buy2,000$113.8418.54view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-10-17Sell200$118.1614.21view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-09-19Sell200$126.176.96view
Mulligan SeamusDirector 2016-08-25Sell27,968$128.325.17view

Quarterly/Annual Reports about JAZZ:

News about JAZZ:

Articles On GuruFocus.com
Cellectar Biosciences' PDC Delivery Platform May Advance Treatment of Multiple Myeloma Feb 13 2017 
Actinium Pharmaceuticals Is Better Than Celator Feb 07 2017 
9 Stocks Trading Below the Peter Lynch Value Jan 11 2017 
Industrial Companies Showing Good Potential for 2017 Jan 04 2017 
Gurus and Insiders Invest in Industrial and Medical Companies Dec 30 2016 
U.S. Elections: What They Might Mean for Investors - JOHCM Commentary Nov 29 2016 
Gurus Invest in Undervalued Biotech Stocks Nov 25 2016 
5 Attractive Biotechnology Stocks for Healthy Long-term Returns Jun 10 2016 
Stocks Fisher Investments Has Bought for Past 2 Quarters May 03 2016 
Citigroup, Amgen Are Trading With Wide Margin of Safety Mar 30 2016 

More From Other Websites
Jazz Pharmaceuticals to Report 2016 Fourth Quarter and Full Year Financial Results on February 28,... Feb 14 2017
5 Drug Stocks Poised to Beat Earnings Estimates in Q4 Feb 09 2017
Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Study Evaluating JZP-110... Feb 08 2017
Actinium Pharmaceuticals Is Better Than Celator Feb 07 2017
Jazz Pharmaceuticals Manufacturing Plant Gets Warning Jan 27 2017
Jazz Pharmaceuticals Plc: Leads amongst peers with strong fundamentals Jan 19 2017
Can Jazz Pharmaceuticals Be a Top Choice for Value Investors? Jan 19 2017
Jazz Rebuffs Concerns Of Generic Sleep Drug Amid Patent Litigation Jan 18 2017
Wednesday’s Top Biopharma Winners Jan 18 2017
FDA Approves Generic of Jazz Pharma's Sleep Drug Jan 18 2017
Jazz Begins Phase III Study for Label Expansion of Defitelio Jan 18 2017
JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Other Events Jan 18 2017
Neurocrine Med Failure, Jazz Pharma Generic Rival OK Sends Both Down Jan 17 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)